4 Recession-Proof Shares Waiting To Be Bought

Published in Investing on 30 June 2010

Double dip recession fears spook world markets. We're on course for a drop of crash proportions. Should you sell now?

Newsflash.

  • FTSE plunges below 5,000.
  • Dow slumps below 10,000.
  • Chinese growth weakens.
  • American consumer confidence falls.
  • Europe still in debt.
  • A Brit still in Wimbledon.

Alert, alert…

Economy, we have a problem. A global double-dip recession could be on the cards.

Yields on 10-year US Treasuries, the global benchmark for future inflationary expectations, dipped below 3%. In the Financial Times, David Ader at CRT Capital said "Yields have priced in a huge amount of bad news for the economy during the second half of the year."

Deflation is the market's new reason to be fearful. Markets are jittery, to say the least. The Great Stock Market Rally of March 2009 to April 2010 has quickly been confined to history. Since peaking at 5,833, in the middle of April, the FTSE has plunged almost 16%.

A Painful, Fearful Drop

A 10% drop is commonly known as a correction. A 16% drop is painful. A 20% drop might be called a crash. The near 50% fall we had from the FTSE's 2007 peak to its March 2009 bottom is commonly called wealth destroying and pretty flipping depressing.

If a 20% fall is known as a crash, we're mighty close to crash territory already.

Markets are super-fearful right now. The fear gauge, otherwise known as the VIX index in the US, soared 18% to 34. According to Bloomberg, the index, which measures the cost of using options as insurance against declines in the S&P 500, is way above its two decade average of 20.

So, what's ahead for battered and bruised investors like you and I?

The Dreaded Double Dip Recession

As ever, the future is uncertain. That said, I doubt we'll be looking at a full-blown financial crisis like we had back in October 2008. Those events come around once in a lifetime.

Maybe there will be a double-dip recession. I've been saying for quite some time now that I expected a tepid economic recovery -- a drawn out period of slow economic growth, coupled with continued very low interest rates. We may even fall back into negative growth territory for two quarters in a row, the dreaded double dip recession.

It's not a reason to suddenly abandon the stock market. If nothing else, the events of October 2008 to April 2010 should have taught investors some very relevant lessons. In times like these, it's worth remembering strong companies with modest levels of debt get through recessions largely unscathed. Sure, their valuations take a beating in the darkest days, but their cash generation and dividend paying records remain intact.

4 Companies Growing Out Of Recession

For example, look at the record of these companies. Taking 2008 as the base year, the year prior to the recession really hitting, and looking forward to 2011 forecasts, their dividend and earnings growth records are very impressive.

Company3-year F'cast
Dividend Growth
3-year F'cast
Earnings Growth
2008
Average P/E
2011
Forecast P/E
Tesco (LSE: TSCO)43.0%26.2%16.112.2
Unilever (LSE: ULVR)41.2%17.2%14.812.7
GlaxoSmithKline (LSE: GSK)26.0%12.7%11.79.2
Smith & Nephew (LSE: SN)77.8%45.6%24.312.1

As you can see, the main thing that's changed about each company is its P/E ratio.

Dreaming Of Such Cheap Stocks

Which brings me onto why we should not expect another almighty stock market crash. This time around, valuations are relatively modest. I counted 25 FTSE 100 companies trading a forecast P/Es of less than 10.

I used to dream of buying decent companies at such modest valuations. Today I feel like a kid in a candy store.

Now admittedly, many of those cheap stocks are companies I'm steering well clear of, including the big miners like Rio Tinto (LSE: RIO) and banks like Barclays (LSE: BARC). But there are plenty of others to choose from, including Glaxo, Royal Dutch Shell (LSE: RDSB) and Vodafone (LSE: VOD), all of which I have positions in.

Genius Or Imbecile?

Just over a year ago, I documented the reasons as to why I sold my entire holding in Barclays at around 300p. In the ensuing 12 months, I've looked like an imbecile when the shares hit 380p in October last year, and a genius on days like today, when the shares trade around 270p.

Such is life as a stock market investor. Genius one day, idiot the next. Yesterday we all looked like idiots, especially if we owned big fallers like Carpetright (LSE: CPR) and Yell Group (LSE: YELL). Today is a new day. Anything could happen tomorrow.

In this day and age of instant news, cheap fees and electronic trading, share prices can move quickly. They are cyclical. They were up in April, down in May, up again 2 weeks ago, and down again today.

Your goal as an investor is not to sell when share prices are at a cyclical low. As such, I wouldn't be a seller today. If you were in the selling mood, April was your time to do that. It's a buyers market today.

More on the economy and the markets:

> If you're in the market for buying shares, consider opening an online broker account with The Motley Fool's Share Dealing Service. You can buy and sell shares in real time for a flat rate of just £10. Click here to find out how you can open an account for free today. 

> Bruce Jackson has positions in Shell, Vodafone and GlaxoSmithKline.

Share & subscribe

Comments

The opinions expressed here are those of the individual writers and are not representative of The Motley Fool. If you spot any comments that are unsuitable hit the flag to alert our moderators.

HenryScottTuke 30 Jun 2010 , 1:48pm

Pedantic I know, but I like correct syntax/semantics - "4 Companies Growing Our Of Recession".

bouleversee 30 Jun 2010 , 3:03pm

Have you compared Glaxo and Carpetright over the past 10 years? The latter may have performed rather badly in the last couple of years - who hasn't? - but Glaxo's performance dipped long before that and whereas I am not losing on my Carpetright I am losing quite a lot on my Glaxo over a long period. Despite the repeated plugs the latter get here, they never seem to do much to deserve them.

F958B 30 Jun 2010 , 5:38pm

bouleversee

Glaxo have steadily proceeded to double their earnings per share and dividend per share in the last several years.
They also continued paying dividends through the recent recession.
That's a good performance from a good company.

The share price hasn't followed the profits upwards because, in my opinion, the shares were overvalued until the 2008-09 crash.
Now the shares are cheap; they're out of fashion and unloved.
I consider Glaxo shares to have a "fair value" of about £15-16 per share.

I recently added GSK (and AZN) to my portfolio. Each is about 7% of total portfolio, at today's prices.

Fingered 30 Jun 2010 , 6:57pm

Bouleversee,not sure if you are French or not.......if you are losing a lot consistently on GSK over a long period of time, watch price levels carefully, it's hovering on key support price ....decide the point at which: "il faut prendre la poudre de l'escampette",

jaizan 30 Jun 2010 , 10:52pm

Glaxo's model is based on selling high margin patented drugs.
After the patents expire, don't they need to compete against all the Indian generic manufacturers?

F958B 30 Jun 2010 , 11:38pm

Yes, GSK need to keep developing new drugs to replace those that go "off patent".
Some drugs can have their patent extended in certain circumstances.

GSK's pipeline is reasonable.
A link to their pipeline is here:
http://www.gsk.com/investors/product_pipeline/docs/GSK-product-pipeline-Feb-2010.pdf

They also make quite a few non-prescription-drug items.
A link to GSK's list of products from their website:
http://www.gsk.com/products/index.htm
A lot of noise was made the other day about GSK's imminent launch of Locozade and similar products in the USA.

During the recent stockmarket rout, Glaxo bought-out a generic manufacturer to strengthen their position in that part of the market.

*
Disclaimer:
I have a 7% portfolio allocation to GSK.

Fingered 30 Jun 2010 , 11:39pm

Great model jaizan ......at the end of the day, who really gives a stuff about fancy modelling when stock prices are hammered by Mr Market.

Fingered 01 Jul 2010 , 12:00am

F958B. ....well matey, if you are really that taken-in and convinced by the Rah-Rah Pharma sector defensive play high dividend Bull/S*** .......go ahead.... knock yourself out, back up your truck and load up on stock with GSK.AZN etc ,..... perhaps they have in their secret development pipeline also drugs (not yet patented and not yet generic for general avaliabiltiy, for cheap release to Africa etc ) to combat unsolicited investors' withdrawal symptoms of streaming streaming eyes,acute gut wrenching pains, sweaty palms, heart palpitations in order to combat the over-optimism of market fundamentals?

Fingered 01 Jul 2010 , 12:04am

Me....I'm shorting that sector........

F958B 01 Jul 2010 , 7:47pm

Fingered.

Yes, I am "taken in" by the bullshine of the two big pharamaceuticals.

Part of my AZN decision was their huge cash pile and no debt.
If the stockmarket plummets, AZN will have the ready cash to buy out some of their competitors at rock bottom prices, which would then reinvigorate AZN's future earnings prospects.

The two big pharmaceuticals (AZN ang GSK) have acceptable earnings prospects, low P/E's and big dividends.
Both came through the 2008-09 recession, increasing both profits and dividends.

AZN and GSK are very welcome in my portfolio; 7% weighting in each.

Maybe the shares will go lower and the shorts - such as yourself - will have some fun.
But I bought them as part of a high-yield portfolio, with the specific objective of milking the long-term dividend payments.
The money to buy them came largely from selling some of my very profitable gold positions. Today's hammering of the gold price makes me glad that I managed to take some gold profits off the table.

Each holding in my portfolio is viewed like a piston in an engine.
In any given month, some go up, some go down.
But overall, they should gradually drive me forwards, even if one or two pistons aren't firing properly.

Even if all I do is pocket the 5.5% net dividend yields, the yield alone looks very attractive in this very low-growth, low-rate environment.

Fingered 01 Jul 2010 , 11:38pm

Well good luck with the spluttering pistons and dividend milking F958B :-)

Join the conversation

Please take note - some tags have changed.

Line breaks are converted automatically.

You may use the following tags in your post: [b]bolded text[/b], [i]italicised text[/i]. All other tags will be removed from your post.

If you want to add a link, please ensure you type it as http://www.fool.co.uk as opposed to www.fool.co.uk.

Hello stranger

To add your own comment, please login.

Not yet registered? Register now.